TELA BIO INC's ticker is TELA and the CUSIP is 872381108. A total of 45 filers reported holding TELA BIO INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $32,885,672 | -21.0% | 4,110,709 | 0.0% | 28.99% | -8.0% |
Q2 2023 | $41,641,482 | -4.8% | 4,110,709 | 0.0% | 31.52% | +24.5% |
Q1 2023 | $43,737,944 | -7.5% | 4,110,709 | 0.0% | 25.31% | -4.0% |
Q4 2022 | $47,273,154 | +35.0% | 4,110,709 | 0.0% | 26.36% | +82.1% |
Q3 2022 | $35,023,000 | +40.1% | 4,110,709 | +15.3% | 14.47% | +40.1% |
Q2 2022 | $24,996,000 | -35.2% | 3,565,709 | +7.5% | 10.33% | +10.8% |
Q1 2022 | $38,568,000 | +58.1% | 3,316,236 | +74.0% | 9.32% | +69.9% |
Q4 2021 | $24,400,000 | -2.6% | 1,906,228 | +3.9% | 5.49% | -1.3% |
Q3 2021 | $25,052,000 | -1.6% | 1,833,989 | +16.1% | 5.56% | +47.8% |
Q2 2021 | $25,455,000 | +8.1% | 1,580,089 | 0.0% | 3.76% | +2.2% |
Q1 2021 | $23,543,000 | +6.1% | 1,580,089 | +7.1% | 3.68% | -36.1% |
Q4 2020 | $22,188,000 | -9.1% | 1,475,293 | 0.0% | 5.76% | -55.6% |
Q3 2020 | $24,401,000 | +35.3% | 1,475,293 | +6.0% | 12.96% | +46.5% |
Q2 2020 | $18,037,000 | +114.7% | 1,391,768 | +29.6% | 8.85% | +63.6% |
Q1 2020 | $8,400,000 | -15.7% | 1,074,231 | +39.6% | 5.41% | +16.4% |
Q4 2019 | $9,962,000 | – | 769,231 | – | 4.65% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Essex Woodlands Management, Inc. | 4,110,709 | $43,737,944 | 25.31% |
Velan Capital Investment Management LP | 746,087 | $7,938,366 | 6.77% |
Opaleye Management Inc. | 2,072,813 | $22,054,730 | 6.61% |
AIGH Capital Management LLC | 1,653,619 | $17,594,506 | 6.48% |
Worth Venture Partners, LLC | 409,649 | $4,358,665 | 2.13% |
JACOB ASSET MANAGEMENT OF NEW YORK LLC | 150,775 | $1,604,246 | 1.87% |
Kamunting Street Capital Management, L.P. | 136,500 | $1,452,360 | 1.85% |
PERKINS CAPITAL MANAGEMENT INC | 166,500 | $1,772 | 1.67% |
NEXT CENTURY GROWTH INVESTORS LLC | 777,753 | $8,275,291 | 0.91% |
Orbimed Advisors | 3,027,542 | $32,213,047 | 0.63% |